Indacaterol

Details

Files

Generic Name:

Indacaterol

Project Status:

Complete

Therapeutic Area:

Chronic obstructive pulmonary disease

Manufacturer:

Novartis Pharmaceuticals Canada Inc.

Call for patient/clinician input open:

February 15, 2012

Brand Name:

Onbrez

Project Line:

Reimbursement Review

Project Number:

SR0273-000

Call for patient/clinician input closed:

March 20, 2012

NOC Status at Filing:

Post NOC

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Chronic Obstructive Pulmonary Disease (COPD), maintenance bronchodilator treatment

Recommendation Type:

List in a similar manner

Final Recommendation:

August 16, 2012

Last Updated : February 29, 2012